The RAD18 (E3) ubiquitin ligase, a key DNA damage tolerance regulator that also functions in DNA double-strand break repair, is overexpressed in the brain cancer glioblastoma. Here, we show that RAD18 promotes glioblastoma cell proliferation in the absence of exogenous damage, independently of its catalytic activity. RAD18 downregulation arrests glioblastoma cells in the G1 phase of the cell cycle, leading to senescence onset, with no apparent increase in DNA damage. We also show that RAD18 sustains glioblastoma stem cells' self-renewal and the growth of tumor orthotropic xenografts in mice. Further, we show that increased RAD18 expression enhances the growth of non-transformed cells and induces the features of oncogenic transformation. Mechanistically, RAD18 interacts and negatively regulates the NF2 tumor suppressor through its SAP domain, thereby facilitating stabilization and nuclear retention of the YAP1 transcription factor. Altogether, these data propose RAD18 as a key target to sensitize glioblastoma to therapy.
Quantitative analyses of per- and polyfluoroalkyl substances (PFAS) commonly rely on low-resolution targeted tandem mass spectrometry (MS/MS) due to its high sensitivity and relatively low operational threshold. Perfluoro-3,5,7,9-butaoxadecanoic acid (PFO4DA), an important constituent of the perfluoropolyether carboxylic acid (PFECA) family, has been widely detected in biotic and abiotic matrices. Nevertheless, marked interference has been observed in the MS/MS transition for PFO4DA (377 > 85) in biological samples, particularly in aquatic organisms, resulting in substantial overestimation of concentrations, reaching up to 66 ng/g. In this study, nontargeted molecular networking strategies, combined with the spectral simulation tools SIRIUS and QCxMS, were applied to identify the source of interference, which was confirmed as an oxygenated metabolite of docosahexaenoic acid (DHA) based on fragmentation patterns matching reference standards. The study further clarified that fatty acids generated the fragment ion [C4H5O2](-) (85.0296 Da), which overlapped with the [CF3O](-) (84.9907 Da) ion of PFECA compounds under low-resolution conditions, causing signal interference. Analysis of river water and fish samples revealed that this interference led to a 24-fold overestimation of PFO4DA bioaccumulation in aquatic organisms. These findings are essential for improving the selectivity of environmental exposure assessments for PFECA compounds.
SiRNA are promising therapeutic molecules that require delivery systems to reach their targets. Several siRNA delivery systems, such as lipid- or peptide-based nanoparticles, have been developed. In this context, we previously conceived a cell-penetrating peptide WRAP5 forming nanoparticles in the presence of siRNAs and validated the efficiency of this delivery system in inhibiting protein expression. In the pathophysiological context of acute myocardial infarction, which causes a pH drop in the ischemic heart tissue, we optimized the WRAP5-based nanoparticles for a pH-sensitive siRNA-targeted delivery. Therefore, pH-sensitive acyl hydrazone linkers were used to graft polyethylene (PEG) on the WRAP5 peptide. Proof of concept of the targeted delivery was performed using siRNA silencing the Fas-associated death domain (FADD) containing protein implicated in apoptosis during myocardial ischemia-reperfusion injury on two human cell models (vascular endothelial cells and hiPSC-derived cardiomyocytes). Our results show that only WRAP5 nanoparticles PEGylated via an appropriate acyl hydrazone linker with tuned pH sensitivity can induce a specific FADD knockdown at pH 5 compared to naked nanoparticles. These optimized WRAP-based nanoparticles could be a novel therapeutic tool for treating myocardial infarction by inhibiting apoptosis induced by reperfusion and maximizing local delivery of the nanoparticle content at the site of injured cells.
The development of non-canonical amino acids is pivotal to peptide engineering, enabling the design of molecules with novel structural features, improved activities, and optimized metabolic profiles. Among these, heteroaromatic γ-amino acids have attracted significant attention for their ability to mimic native peptide folds while accessing novel conformational spaces. In this study, the chemical diversity of heteroaromatic γ-amino acids was expanded by introducing two new monomers, ATC* and AOC*, designed around a thiazole and an oxazole scaffold, respectively. These analogues, characterized by their tunable substitution patterns and precise stereochemical control significantly expand the well-established ATC family.